Document Detail


Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
MedLine Citation:
PMID:  10770179     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Incidentally discovered adrenal masses are mostly benign, asymptomatic lesions, often arbitrarily considered as nonfunctioning tumors. Recent studies, however, have reported increasing evidence that subtle cortisol production and abnormalities in the hypothalamic-pituitary-adrenal (HPA) axis are more frequent than previously thought. The purpose of this study was to investigate the clinical and hormonal features of patients with incidentally discovered adrenal adenomas, in relation to their clinical outcome. Fifty consecutive patients with incidentally detected adrenal adenomas, selected from a total of 65 cases of adrenal incidentalomas, were prospectively evaluated. All of them underwent abdominal computed tomography scan and hormonal assays of the HPA axis function: circadian rhythm of plasma cortisol and ACTH, urinary cortisol excretion, 17-hydroxyprogesterone, androgens, corticotropin stimulation test and low-dose (2 mg) dexamethasone test. The patients were reevaluated at regular intervals (6, 12, and 24 months) for a median period of 38 months. Subtle hypercortisolism, defined as abnormal response to at least 2 standard tests of the HPA axis function in the absence of clinical signs of Cushing's syndrome (CS), was defined as subclinical CS. Mild-to-severe hypertension was found in 24 of 50 (48%) patients, type-2 diabetes in 12 of 50 (24%), and glucose intolerance in 6 of 50 (12%) patients. Moreover, 18 of 50 patients (36%) were diffusely obese (body mass index, determined as weight/height2, > 25), and 14 patients (28%) had serum lipid concentration abnormalities (cholesterol > or = 6.21 mmol/L, low-density lipoprotein cholesterol > or = 4.14 mmol/L and/or triglycerides > or = 1.8 mmol/L). Compared with a healthy population, bone mineral density Z-score, determined by the DEXA technique, tended to be slightly (but not significantly) lower in patients with adrenal adenoma (-0.41 SD). Endocrine data were compared with 107 sex- and age-matched controls, and patients with adenomas were found to have heterogeneous hormonal abnormalities. In particular, significantly higher serum cortisol values (P < 0.001), lower ACTH concentration (P < 0.05), and impaired cortisol suppression by dexamethasone (P < 0.001) were observed. Moreover, in patients with adenomas, cortisol, 17-OH progesterone, and androstenedione responses to corticotropin were significantly increased (P < 0.001, all), whereas dehydroepiandrosterone sulfate levels were significantly lower at baseline, with blunted response to corticotropin (P < 0.001, both). However, the criteria for subclinical CS were met by 12 of 50 (24%) patients. Of these, 6 (50%) were diffusely obese, 11 (91.6%) had mild-to-severe hypertension, 5 (41.6%) had type-2 diabetes mellitus, and 6 (50%) had abnormal serum lipids. The clinical and hormonal features improved in all patients treated by adrenalectomy, but seemed unchanged in all those who did not undergo surgery (follow-up, 9 to 73 months), except for one, who was previously found as having nonfunctioning adenoma and then revealed to have subclinical CS. In conclusion, an unexpectedly high prevalence of subtle autonomous cortisol secretion, associated with high occurrence of hypertension, diabetes mellitus, elevated lipids, and diffuse obesity, was found in incidentally discovered adrenal adenomas. Although the pathological entity of a subclinical hypercortisolism state remained mostly stable in time during follow-up, hypertension, metabolic disorders, and hormonal abnormalities improved in all patients treated by adrenalectomy. These findings support the hypothesis that clinically silent hypercortisolism is probably not completely asymptomatic.
Authors:
R Rossi; L Tauchmanova; A Luciano; M Di Martino; C Battista; L Del Viscovo; V Nuzzo; G Lombardi
Related Documents :
11950639 - Preoperative location of the pituitary bright spot in patients with pituitary macroaden...
20634249 - Late-night salivary cortisol in normal subjects and in patients with cushing's syndrome.
2588119 - Idiopathic aldosteronism masquerading as discrete aldosterone-secreting adrenal cortica...
9365329 - Incidental pituitary macroadenoma: a population-based study.
12429039 - Antibodies to pituitary surface antigens during various pituitary disease states.
1431959 - Delayed radiation necrosis of the central nervous system in patients irradiated for pit...
14696409 - Evaluation of hepatic functions and biliary dynamics in patients with liver cirrhosis b...
17942779 - Long-term survival of incident hemodialysis patients who are hospitalized for congestiv...
19032819 - Listeria monocytogenes infection in patients with rheumatic diseases on tnf-alpha antag...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  85     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2000 Apr 
Date Detail:
Created Date:  2000-05-01     Completed Date:  2000-05-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1440-8     Citation Subset:  AIM; IM    
Affiliation:
Dipartimento di Endocrinologia, Università di Napoli Federico II, Italy. tauchman@unina.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
17-alpha-Hydroxyprogesterone / blood
Adenoma / complications*,  radionuclide imaging
Adrenal Gland Neoplasms / complications*,  radionuclide imaging
Adrenal Glands / physiopathology
Adrenocorticotropic Hormone / blood,  diagnostic use
Adult
Aged
Androgens / blood
Cushing Syndrome / complications*,  radionuclide imaging
Dexamethasone / diagnostic use
Female
Humans
Hydrocortisone / blood,  urine
Hypothalamus / physiopathology
Male
Middle Aged
Pituitary Gland / physiopathology
Prospective Studies
Chemical
Reg. No./Substance:
0/Androgens; 50-02-2/Dexamethasone; 50-23-7/Hydrocortisone; 68-96-2/17-alpha-Hydroxyprogesterone; 9002-60-2/Adrenocorticotropic Hormone
Comments/Corrections
Comment In:
J Clin Endocrinol Metab. 2001 Feb;86(2):950-2   [PMID:  11158083 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Integrity of the growth hormone/insulin-like growth factor system is maintained in patients with chr...
Next Document:  A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor ...